LONDON, July 24 (Xinhua) -- China is reshaping its growth model around strategic self-reliance, innovation-driven productivity, and systemic capabilities, which present fresh opportunities for foreign ...

Collaboration with Chinese innovators is also a key component of AstraZeneca's strategy. Over the past two years, it has signed global licensing agreements with 14 Chinese biotech companies. Through ...